Theravance Biopharma (TBPH) EBITDA Margin (2013 - 2026)
Theravance Biopharma's EBITDA Margin was -38.16% in Q2 2026, down 29.31 percentage points from -8.84% a year earlier but up 13.27 percentage points from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) EBITDA Margin (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Theravance Biopharma's EBITDA Margin was -2.54% through Jun 30, 2026, up 43.47 percentage points year-over-year; for FY2025, it was -1.84%, up 68.43 percentage points from FY2024.
- EBITDA Margin has now increased for four consecutive years, with a five-year change of +405.80 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -70.27% in FY2024 (+23.83 pp), -94.10% in FY2023 (+77.76 pp), -171.86% in FY2022 (+285.53 pp) and -457.38% in FY2021 (-49.74 pp).
- Quarterly EBITDA Margin has moved between -394.04% (Q3 2021) and 44.48% (Q4 2025) over five years.
- Compared with a year earlier, EBITDA Margin was higher in four of the last eight quarters, with an average year-over-year change of +24.06 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2022 (a gain of 329.50 percentage points); the worst was Q2 2026 (a drop of 29.31 percentage points).
- Per Business Quant data, TBPH's EBITDA Margin in the three quarters before Q2 2026 was -51.43% (Q1 2026), 44.48% (Q4 2025) and -30.27% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | -38.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.16% |
| Mar 31, 2026 | -51.43% |
| Dec 31, 2025 | 44.48% |
| Sep 30, 2025 | -30.27% |
| Jun 30, 2025 | -8.84% |
| Mar 31, 2025 | -91.12% |
| Dec 31, 2024 | -46.81% |
| Sep 30, 2024 | -61.70% |
| Jun 30, 2024 | -107.17% |
| Mar 31, 2024 | -74.29% |
| Dec 31, 2023 | -33.29% |
| Sep 30, 2023 | -53.07% |
| Jun 30, 2023 | -113.25% |
| Mar 31, 2023 | -233.15% |
| Dec 31, 2022 | -114.50% |
| Sep 30, 2022 | -64.54% |
| Jun 30, 2022 | -234.48% |
| Mar 31, 2022 | -284.34% |
| Dec 31, 2021 | -374.12% |
| Sep 30, 2021 | -394.04% |
API Access
Theravance Biopharma EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();